Company news
Rakovina Therapeutics Inc (TSXV:RKV) news
Rakovina Therapeutics Inc news releases on 6ix. Latest, Apr 29, 2025: Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer…
Press releases — page 2
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
April 29, 2025
Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel
April 28, 2025
Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery
April 22, 2025
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World's Premier Cancer Research Forum
March 25, 2025
Next-Gen Cancer Treatment: Rakovina's AI-Driven ATR Inhibitors Enter Preclinical Testing
March 12, 2025
Rakovina Therapeutics and Variational AI Strengthen Partnership
February 26, 2025
Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration
April 2, 2024
Rakovina Therapeutics continues to make progress as company provides corporate update
September 13, 2023
Rakovina Therapeutics shares new kt-3000 data at American Association of Cancer Research event
April 24, 2023
Rakovina Therapeutics receives government grant to accelerate novel cancer therapy program
March 24, 2023
Rakovina Therapeutics: Transform & Extend the Lives of Patients with Cancer, CEO Clip Video
May 27, 2022
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
December 20, 2021
InvestmentPitch Media Video Discusses Rakovina Therapeutics' Partnership with St. Baldrick's Foundation to Research and Develop New Treatments for Childhood Bone Cancer - Video Available on Investmentpitch.com
November 17, 2021
The Power Play by The Market Herald Releases New Interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy DeFi, and Saturn Oil & Gas Discussing Their Latest Press Releases
November 16, 2021
InvestmentPitch Media Video Discusses Rakovina Therapeutics' Receipt of Notice of Allowance for New U.S. Patent Covering kt-2000 Series PARP Inhibitors - Video Available on Investmentpitch.com
October 8, 2021
Rakovina Therapeutics to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
August 17, 2021
Red Thread Ventures' portfolio company Rakovina Therapeutics'
August 11, 2021
Rakovina Therapeutics Announces Results from Annual General Meeting
June 29, 2021
Rakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021
June 17, 2021
Rakovina Therapeutics Inc. Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 27, 2021
Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory Board
April 29, 2021
Rakovina Therapeutics Inc. Receives European and Canadian Patents on kt-2000 series PARP-inhibitors
April 8, 2021
Rakovina Therapeutics Inc. Appoints Biotechnology Industry Veteran Julie M. Cherrington, PhD to Board of Directors
April 5, 2021
InvestmentPitch Media Video Discusses Newly Listed Rakovina Therapeutics, a Developer of New Cancer Treatments Targeting Critical DNA Damage Response Mutations - Video Available on Investmentpitch.com
April 5, 2021
Rakovina Therapeutics Inc. Commences Trading on TSX Venture Exchange Under Ticker Symbol "RKV"
April 1, 2021